These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 19151457)
1. Angiotensin receptor blockers: current status and future prospects. Kumar S; Ram CV Indian Heart J; 2007; 59(6):443-53. PubMed ID: 19151457 [No Abstract] [Full Text] [Related]
2. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET? Ram CV; Deedwania PC Am J Cardiol; 2008 Nov; 102(9):1281-3. PubMed ID: 18940307 [No Abstract] [Full Text] [Related]
3. [Renin-angiotensin system modulation: instructions for use]. Bellis A; Rozza F; Crispo S; Trimarco B G Ital Cardiol (Rome); 2008 Feb; 9(2):79-89. PubMed ID: 18383770 [TBL] [Abstract][Full Text] [Related]
4. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction? McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527 [No Abstract] [Full Text] [Related]
5. Blocking the renin-angiotensin system: dual- versus mono-therapy. Ravandi A; Teo KK Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282 [TBL] [Abstract][Full Text] [Related]
6. Antihypertensive strategy based on angiotensin II receptor blockers: a new gateway to reduce risk in hypertension. Tocci G; Sciarretta S; Facciolo C; Volpe M Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):767-76. PubMed ID: 17605654 [TBL] [Abstract][Full Text] [Related]
7. Moving beyond angiotensin II to also target aldosterone? Little WC; Kirkman PM J Am Coll Cardiol; 2009 Aug; 54(6):513-4. PubMed ID: 19643311 [No Abstract] [Full Text] [Related]
8. Angiotensin receptor blockers: novel role in high-risk patients. Javed U; Deedwania PC Cardiol Clin; 2008 Nov; 26(4):507-26. PubMed ID: 18929228 [TBL] [Abstract][Full Text] [Related]
9. Inhibiting the renin-angiotensin system: why and in which patients. Berra K; Miller NH J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897 [TBL] [Abstract][Full Text] [Related]
10. [Renin-angiotensin-aldosterone system (RAAS) and its pharmacologic modulation]. Giestas A; Palma I; Ramos MH Acta Med Port; 2010; 23(4):677-88. PubMed ID: 20687997 [TBL] [Abstract][Full Text] [Related]
12. [Multilevel blockade of the renin-angiotensin-aldosterone system in the treatment of diabetic nephropathy]. Fronczyk A; Majkowska L Przegl Lek; 2007; 64(2):81-5. PubMed ID: 17892038 [TBL] [Abstract][Full Text] [Related]
14. Use of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker therapy to reduce cardiovascular events in high-risk patients: part 2. Bommer WJ Prev Cardiol; 2008; 11(4):215-22. PubMed ID: 19476574 [TBL] [Abstract][Full Text] [Related]
15. What is the role of angiotensin-receptor blockade in cardiovascular protection? Cohn JN Am Heart J; 2006 Nov; 152(5):859.e1-8. PubMed ID: 17070145 [TBL] [Abstract][Full Text] [Related]
16. Dual blockade of the renin-angiotensin system for cardiorenal protection: an update. Arici M; Erdem Y Am J Kidney Dis; 2009 Feb; 53(2):332-45. PubMed ID: 19166800 [TBL] [Abstract][Full Text] [Related]
18. Protective effects of angiotensin II interruption: evidence for antiinflammatory actions. Dagenais NJ; Jamali F Pharmacotherapy; 2005 Sep; 25(9):1213-29. PubMed ID: 16164395 [TBL] [Abstract][Full Text] [Related]
19. Should angiotensin II receptor blockers and statins be combined? Nickenig G Circulation; 2004 Aug; 110(8):1013-20. PubMed ID: 15326080 [No Abstract] [Full Text] [Related]
20. Renin-angiotensin system inhibitors for prevention of new-onset atrial fibrillation. Baker WL; White CM Conn Med; 2007 Apr; 71(4):205-9. PubMed ID: 17487005 [No Abstract] [Full Text] [Related] [Next] [New Search]